Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
93.72
+0.18 (0.19%)
Nov 6, 2026, 4:00 PM EST - Market closed
Mirum Pharmaceuticals Employees
Mirum Pharmaceuticals had 470 employees as of September 30, 2026. The number of employees increased by 115 or 32.39% compared to the same quarter last year. That makes Mirum Pharmaceuticals the 20,558th largest employer in the world and 2,734th in the United States.
Employees
470
Change (1Y)
115
Growth (1Y)
32.39%
Revenue / Employee
$1,427,187
Profits / Employee
-$1,923,145
Market Cap
6.12B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2026 | 470 | 115 | 32.39% | 470 | 0 |
| Jun 30, 2026 | 433 | 84 | 24.07% | 433 | 0 |
| Mar 31, 2026 | 418 | 84 | 25.15% | 418 | 0 |
| Dec 31, 2025 | 372 | 50 | 15.53% | 369 | 3 |
| Sep 30, 2025 | 355 | 44 | 14.15% | 355 | 0 |
| Jun 30, 2025 | 349 | 55 | 18.71% | 349 | 0 |
| Mar 31, 2025 | 334 | 56 | 20.14% | 334 | 0 |
| Dec 31, 2024 | 322 | 58 | 21.97% | 322 | 0 |
| Sep 30, 2024 | 311 | 62 | 24.90% | 311 | 0 |
| Jun 30, 2024 | 294 | 81 | 38.03% | 294 | 0 |
| Mar 31, 2024 | 278 | 78 | 39.00% | 278 | 0 |
| Dec 31, 2023 | 264 | 68 | 34.69% | 264 | 0 |
| Sep 30, 2023 | 249 | 55 | 28.35% | 249 | 0 |
| Jun 30, 2023 | 213 | 42 | 24.56% | 213 | 0 |
| Mar 31, 2023 | 200 | 56 | 38.89% | 200 | 0 |
| Dec 31, 2022 | 196 | 59 | 43.07% | 196 | 0 |
| Sep 30, 2022 | 194 | 57 | 41.61% | 194 | 0 |
| Jun 30, 2022 | 171 | 51 | 42.50% | 171 | 0 |
| Mar 31, 2022 | 144 | 59 | 69.41% | 144 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ionis Pharmaceuticals | 1,480 |
| Axsome Therapeutics | 1,390 |
| PTC Therapeutics | 991 |
| Rhythm Pharmaceuticals | 414 |
| Immunovant | 315 |
| Scholar Rock Holding | 289 |
| CG Oncology | 142 |
| Kodiak Sciences | 141 |
MIRM News
- 2 days ago - GeneDx, Mirum launch sponsored testing programs - TheFly
- 2 days ago - GeneDx and Mirum Pharmaceuticals Launch Sponsored Testing Programs to Help Patients Find Answers Through Comprehensive Genetic Testing - Business Wire
- 3 days ago - Mirum Pharmaceuticals price target raised to $160 from $155 at Cantor Fitzgerald - TheFly
- 3 days ago - Mirum Pharmaceuticals price target raised to $202 from $200 at H.C. Wainwright - TheFly
- 3 days ago - Mirum Pharmaceuticals price target raised to $167 from $144 at Citizens - TheFly
- 3 days ago - Mirum Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Mirum Pharmaceuticals Earnings release: Q3 2026 - Filings
- 3 days ago - Mirum Pharmaceuticals Quarterly report: Q3 2026 - Filings